| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Editas Medicine, Inc. (EDIT) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. EDIT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.1K | $723.8K | - | |
| VP | 68.8K | $185.0K | - | |
| CFO | 15.9K | $42.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2018 | Bosley Katrine | President And CEO | Sell | 12,000 | $32.35 | $388,210.40 | -0.5% | |
| Aug 31, 2018 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 10,000 | $32.23 | $322,300.00 | -100% | |
| Aug 20, 2018 | Bosley Katrine | President And CEO | Sell | 12,000 | $30.17 | $362,007.84 | -0.5% | |
| Aug 20, 2018 | Myer Vickesh | Chief Technology Officer | Sale+OE | 7,000 | $29.78 | $208,430.00 | -100% | |
| Aug 1, 2018 | Bosley Katrine | President And CEO | Sell | 8,333 | $29.55 | $246,252.88 | -0.3% | |
| Jul 18, 2018 | Myer Vickesh | Chief Technology Officer | Sale+OE | 14,000 | $35.63 | $498,871.50 | -100% | |
| Jul 2, 2018 | Bosley Katrine | President And CEO | Sell | 8,333 | $36.29 | $302,441.18 | -0.3% | |
| Jun 19, 2018 | Myer Vickesh | Chief Technology Officer | Sale+OE | 14,000 | $38.26 | $535,572.00 | -100% | |
| Jun 13, 2018 | Albright Charles | Chief Scientific Officer | Sale+OE | 10,000 | $35.98 | $359,800.00 | -100% | |
| Jun 4, 2018 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 10,000 | $38.63 | $386,270.00 | -100% |